Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | EW | DXCM |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.4800 | 577.40 | 374.12 | 88.00 | 138.91 |
| High | 1.5700 | 577.99 | 375.46 | 88.73 | 139.24 |
| Low | 1.4500 | 569.98 | 367.66 | 86.66 | 134.39 |
| Last | 1.5200 | 571.73 | 373.12 | 88.01 | 138.01 |
| Change | +0.0200 | -5.66 | -1.89 | -0.60 | +0.14 |
| % Change | +1.33% | -0.98% | -0.50% | -0.68% | +0.10% |
| Volume | 854,500 | 1,184,000 | 1,262,600 | 4,295,200 | 4,203,100 |
| 20-Day Average Volume | 2,743,230 | 1,371,075 | 1,620,755 | 3,083,485 | 2,535,165 |
| Previous Close | 1.5000 | 577.39 | 375.01 | 88.61 | 137.87 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6862 | 567.79 | 381.68 | 90.49 | 136.59 |
| 20-Day Raw Stochastic | 26.17% | 69.81% | 23.35% | 24.49% | 68.95% |
| 20-Day Relative Strength | 50.86% | 51.81% | 44.85% | 46.86% | 56.26% |
| Weighted Alpha | +97.70 | +7.50 | +25.22 | +6.64 | +23.21 |
| Today's Opinion | 72% Buy | 56% Buy | 40% Buy | 56% Buy | 96% Buy |
| Previous Opinion | 72% Buy | 72% Buy | 40% Buy | 56% Buy | 96% Buy |
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.04% since 04/18/24 | +5.58% since 04/18/24 | +0.13% since 04/18/24 | +1.80% since 04/18/24 | +2.76% since 04/18/24 |
| Low | 1.3200 on 04/22/24 | 539.17 on 04/19/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 129.17 on 04/19/24 |
| High | 1.5950 on 04/24/24 | 586.46 on 04/24/24 | 388.65 on 04/19/24 | 89.17 on 04/24/24 | 139.24 on 04/25/24 |
| 1-Month | |||||
| %Chg | -19.58% since 03/25/24 | -0.32% since 03/25/24 | -4.75% since 03/25/24 | -5.53% since 03/25/24 | -1.49% since 03/25/24 |
| Low | 1.2400 on 04/18/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 129.17 on 04/19/24 |
| High | 2.3100 on 04/05/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 3-Month | |||||
| %Chg | +90.00% since 01/25/24 | +6.23% since 01/25/24 | -0.49% since 01/25/24 | +19.66% since 01/25/24 | +9.09% since 01/25/24 |
| Low | 0.8000 on 01/26/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 72.71 on 01/29/24 | 113.05 on 02/28/24 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | +131.14% since 10/25/23 | +31.98% since 10/25/23 | +39.95% since 10/25/23 | +28.78% since 10/25/23 | +63.62% since 10/25/23 |
| Low | 0.6200 on 11/13/23 | 420.21 on 10/30/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 80.93 on 10/26/23 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 187,956 | 220,397,840 | 133,018,304 | 53,336,752 | 54,600,104 |
| Shares Outstanding, K | 125,304 | 381,714 | 354,706 | 601,927 | 396,026 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -30,090,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 0 | 10,886,000,000 | 1,890,600,000 | 1,534,100,000 | 1,034,500,000 |
| Last Quarter Net Income | -7,750,000 | 1,630,000,000 | 544,900,000 | 369,900,000 | 256,300,000 |
| 60-Month Beta | 1.20 | 0.80 | 1.36 | 1.05 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/01/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.64 on 02/06/24 | 0.50 on 02/08/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.68 | 80.57 | 34.96 | 88.74 |